Karlsruhe (GER) – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Transmedic Group, a top medical device distributor headquartered in Singapore. In this exclusive deal, Transmedic will represent joimax^® in Singapore, Hong Kong, Philippines and Indonesia. 

The long-term partnership will provide a broader surgical choice for patients considering endoscopic minimally invasive spinal surgery in these markets. With recent advances in the field of endoscopic discectomy (ED), the procedure has potential to supersedemicrodiscectomy (MD) as the gold standard of care in management of lumbar disc disease, as the latest literature suggests. 

“joimax^® is very much looking forward to working with Transmedic Group,” says joimax^® Founder and CEO Wolfgang Ries. “With the rising popularity of endoscopic approaches in the management of spinal diseases, we’re able to deliver the highest standard of patient care, strengthen our sales activities, and enter into another important partnership across APAC.” 

Teo Kee Meng, managing director of Transmedic Group commented, “We’re very pleased to partner with joimax^®. With their technological advancements and use of new spinal access corridors, a major prevention of spinal structure collateral damage is assured, allowing for significantly reduced complications and improved postoperative recovery times.”

About Transmedic Group
Transmedic Group was founded in 1980 with the aim of becoming the top specialist in the advanced medical technology area in Southeast Asia. Headquartered in Singapore, the privately held company has since grown its presence in seven countries with more than 500 employees, and is well-renowned as the leading provider of latest technologies in healthcare.

Karlsruhe (GER) – joimax^® and Trang Thi are pleased to announce their partnership in bringing the joimax^® full-endoscopic and minimally invasive spinal surgery technology to the Southern Provinces of Vietnam including Da Nang market.  joimax^® a German-based company is a recognised market leader in these technologies and training methods with a history of innovation in endoscopic spine surgery since 2001.

Endoscopic Spine Surgery has been growing steadily in popularity since the late 1990’s and there has been exponential growth in the technique in the past 10 years. The distributor Trang Thi and joimax^® are pursuing a long term corporation to provide a broader surgical choice for patients considering spinal surgery.
“joimax^® is looking forward to working with a partner as strong as Trang Thi, says joimax^® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”.

Endoscopy in Pain Therapy

Focus on Facet Joint – Sacroiliac Joint – Peripheral nerves
New Endoscopic Approach

The aim of the Course of Endoscopy in Pain Therapy is to develop endoscopic techniques in the treatment of common diseases like Low Back Pain, Sacroileitis and Peripheral nerves pain. This course gives the participants an overview of endoscopic possibilities and new approaches in Pain Therapy.

The course is divided in two sessions, a frontal didactical part with an explanation of anatomy and physiopathology of facet joint pain, sacroliliac pain and peripheral nerves disturbs, and it is followed by a practice part with 2 / 3 surgical procedures performed by Dr. Meloncelli and his equipe with a direct explanation of surgical aspects.

At a glance:

One day meeting with live surgery
Rome, November 24, 2018, 9:30 – 17:00

Course director: Dr. Stefano Meloncelli
Secretary: Dr. Ignazio Urti
Faculty: Dr. Marco Divizia, Dr. Giorgio Germani

Location:
Casa di Cura „Valle Giulia“
Via Guiseppe de Notaris 2, Roma
www.clinicavallegiulia.it

Number of Participants: 10
Subscription: 600 Euro

Reservation and information:
Medical Training
phone number:+39 329 771 41 69
email: infomedicaltraining@gmail.com

sponsored by

Karlsruhe (GER) — German-based joimax^®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce that it has received FDA clearance to market the EndoLIF^® Delta-Cage and EndoLIF^® DoubleWedge-Cage in the United States. Delta-Cages and DoubleWedge-Cages are intended for intervertebral body fusion procedures for various diseases of the lumbar spine, such as degenerative disc disease.

Many other experts including, Dr. Florian Zentz, head surgeon of the spine center in Tutzing (Munich), Dr. Ricardo Casal Grau, orthospine surgeon from Madrid, and Dr. J. N. Alastair Gibson, spinal surgeon from Edinburgh, supported the development of the joimax^® cages.

“With FDA clearance of two of our cages, our EndoLIF^® platform gets more complete; the next major step in endoscopic spinal surgery is endoscopically-assisted fusion,” says joimax^® Founder and CEO Wolfgang Ries. “More and more centers are proving the efficacy of these procedures in studies, demonstrating once again the major benefits of endoscopy in fusion. So far, our cages are well established in Europe and in selected centers in Asia, and now we are entering the USA, the biggest market for spinal fusion”.

Karlsruhe (GER) / Irvine, CA – December 6, 2018 – joimax^®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, is well positioned for Germany’s principal spine convention, German Spine Society (DWG), taking place December 6 to 8 in Wiesbaden, Germany.

This year, joimax^® is focusing on their Endoscopic Tower Generation 4 Devices, an expert solution for spinal surgery. They will showcase the new Camsource^® LED, a fully integrated camera and light source system that delivers brilliant images up to 4K; and the Vitegra^®, the integrated visualization, documentation and commanding device. This marks the global launch of both devices, including in Europe, Asia, and the United States.

Moreover, joimax^® will exhibit its EndoLIF^® product line: the well-known 3D-printed EndoLIF^® O/On-Cage, the EndoLIF^® Delta Cage, and the EndoLIF^® Double Wedge Cage (approval expected shortly).

“The main advantage of the EndoLIF^® Implants is the gentle and atraumatic access via gradual tissue dilatation — muscles remain intact and infection risk is reduced. Using 3D-printing technology, an open diamond cell structure, and a rough and porous surface, leads to optimal bone ingrowth, stability and finally fusion,” states Wolfgang Ries, Founder and CEO of the joimax^® Group. “Even awake, fusion with very fast patient recovery has started to be realized on the base of endoscopic minimally-invasive techniques.”

Additionally, joimax^®  will show Intracs^{® em}, the first complete electromagnetic navigation system for endoscopic minimally invasive spine surgery. Intracs^® is an easy to set up, user-friendly system that can serve as a stand-alone device. It relies on electromagnetic tracking and was designed specifically for simple and safe access to any spinal target. It’s the only device on the market that allows for simultaneous navigation of multiple instruments such as needles, guiding rods, reamers, and endoscopes, also developed by joimax^®.

Besides an expanded booth presence with daily Meet-the-Expert Sessions, joimax^® will again host two lunch symposiums on endoscopic spinal procedures: one covering endoscopic pain therapy, and the other addressing diverse intracanal surgical treatment modalities, including endoscopic fusion.

IRVINE, CA – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the global launch of its new generation tower, NAVENTO^® Navigation Endoscopic Tower. Optimized for endoscopic spine surgery with special settings for the safe treatment of sensitive structures, NAVENTO^® will be featured at the North American Spine Society (NASS) meeting in Boston later this month and at EUROSPINE in Vienna this October.

NAVENTO^®, the fully integrated fourth generation endo-tower, contains everything a surgeon needs to perform a successful procedure. The tower boasts updated design features for enhanced usability and is composed of six devices that work in unison to give the user the best possible surgical experience:

1. Vitegra^®, the brain of NAVENTO^®, offers complete documentation and data management.
2. Camsource^® LED provides optimal clarity up to 4K resolution.
3. Intracs^®, the newest device from joimax^®, delivers electromagnetic navigation at the instrument’s tip.
4. Shrill^®, the shaver drill system, with the newest generation recently launched, provides optimal RPMs and torque management.
5. Endovapor^® 2 poses electrosurgical offerings for monopolar and bipolar settings.
6. Versicon^®, delivers fluid and pressure regulation.

“joimax^® continues to lead the endoscopic spine market through innovations in technologies aimed to increase the user experience and provide spinal patients with an ultra-minimally invasive treatment option,” stated Christoph Hofstetter, M.D., Ph.D., associate professor in the Department of Neurological Surgery at the University of Washington.

Wolfgang Ries, CEO and founder of the joimax^® group, confirmed, “NAVENTO^® pulls together the latest technologies forming one complete, seamlessly integrated spinal endoscopic package.”

NAVENTO^®, along with the full suite of joimax^® endoscopic technologies will be showcased at NASS, booth #3512, and at EUROSPINE, booth #04.

Karlsruhe, GER– April 18, 2019 – joimax^®, the Germany-based market leader of technologies and training methods for full-endoscopic, minimally-invasive spinal surgery, is presenting its complete product portfolio at the 48^th Annual Meeting of the Japanese Society for Spine Surgery and Related Research (JSSR). The annual meeting is currently underway running April 18-20, 2019 in Yokohama, Japan.

Earlier this year, joimax^® announced its partnership with United Biomech Japan, Inc., who is overseeing distribution of the complete joimax^® product line throughout Japan. Approval of the Pharmaceutical Medicals and Medical Devices Agency (PMDA) is expected within the next couple of months.

“The Japanese market is characterized by a strong demand for innovative products on endoscopic spinal surgery,” explained United Biomech Japan, Inc. Executive Kazuya Oribe. “The interest at our booth is overwhelming. There are approximately one thousand Japanese surgeons that are now already interested in doing endoscopic spinal surgery.”

“The patients’ demand for gentle surgery methods that result in a very quick recovery, is continuously increasing,” said joimax^® Group Founder and CEO Wolfgang Ries. “Our entrance into the Japanese market is another milestone in expanding our global presence to offer superior medical products. Coupled with an outstanding, international training and education program, we’ve positioned ourselves for long-term growth.”

IRVINE, CA – May 13, 2019 – joimax^®,, the Germany-based market leader of technologies and training methods for full-endoscopic, minimally-invasive spinal surgery, is showcasing its Integrated Navigation Tracking & Control System, Intracs^®em, at this year’s Global Spine Congress (GSC), which is currently being held in Toronto, Canada. The company is also promoting the system at the annual meeting of the German Society of Neurosurgery (DGNC), being held concurrently in Wurzburg, Germany.

The Intracs^®em electromagnetic navigation system is simple to set up, very user-friendly, and seamlessly integrates into the joimax^® endoscopic tower. It allows for navigation during any endoscopic procedure performed with the joimax^® endoscopic surgical systems, TESSYS^® (transforaminal) and iLESSYS^® (interlaminar). Beyond that, it can serve as a stand-alone device.

The system relies on electromagnetic tracking, affording simultaneous navigation of multiple instruments such as needles, guiding rods, reamers and endoscopes. It was developed by joimax^®  for easy planning of endoscopic approaches to the spine, as well as other minimally invasive procedures, like percutaneous fusions.

Various Intracs^®em sensors guarantee the highest accuracy. Plus, for the patients’ benefit, the procedure can be carried out without further X-ray control –  only starting X-rays are required. As a result, access, intervention time, and radiation exposure, are reduced to a minimum.

The system is CE-Marked. Currently, clinical trials and applications are running in Europe and Asia, where the product has already launched. In specific Asian countries, like Taiwan, the first systems have been sold and shipped.

Users are very impressed with the usability of the system. “I didn’t expect that navigation for both transforaminal and interlaminar procedures can be made so easy and that the set-up time can be so much streamlined,“ states Prof. Michael Kraus, spine specialist in Augsburg, Germany.  “And for the thoracic approach, it is so precise and a tremendous help,” continues Dr. Erik Traupe, spine specialist in Munich, Germany.

The launch of Intracs^®em is a key milestone for joimax^®. As part of its global strategy, joimax^®  is providing surgeons, worldwide, with the devices they need for safe, easy and gentle spinal therapies, with US-FDA submission planned for Q2, 2019. “We are committed to overcoming any obstacles and concerns related to minimally invasive, endoscopic spine surgery,” states joimax^® CEO and Founder Wolfgang Ries. “Our success lies with our innovative, user-friendly devices and instruments, and our ability to provide both doctor and patient with outstanding safety built into our systems.” Moreover, a well established and targeted clinical training program for the spinal surgical community, named CM3, rounds out the joimax^® educational offering. Earlier this year, joimax^® launched ESPINEA^®, an Endoscopic Spine Academy focused on a complete endoscopic spine curriculum. Designed as a full training program to elevate surgeons to the next level of expertise, ESPINEA^® offers professional and high-quality education for endoscopic spine treatment specialists, worldwide. The ESPINEA^® Training and Education Centers are located in Karlsruhe, Germany in the newly opened joimax^® building, and in Irvine, CA, where joimax^® opened new labs and training rooms last November.

Maximilian Ries

Ries took on the newly created role of Executive Vice President, Business Development and Operations at joimax^®. In this position, based in Germany, he will be responsible for scaling global operations to ensure joimax^® continues its exponential growth. Formerly the General Manager, for the past six of his 13-year tenure with joimax^®, Ries built out the United States and Latin American markets.

Tony Troncale

Troncale was promoted to General Manager; he was formerly Vice President of Marketing and Business Development at joimax^® Inc. Over the past two years, Troncale, in addition to increasing his responsibilities, successfully capitalized on the significant interest in endoscopic techniques to expand US sales operations. He joined joimax^® in 2021 bringing 20-years of experience in the spinal device industry where he served in sales and marketing leadership roles at Stryker, K2M, and Synthes Spine. Contributing to the global organization’s continuous strong sales growth was the launch of a new surgical access system, “Tessys^® Trans SAP” and the global expansion of the ESPINEA^® Education Academy.

Wolfgang Ries

“I am extremely pleased with our 2022 global performance and the significant interest in endoscopic spine surgery,” stated joimax^® Founder and CEO Wolfgang Ries. “With Max and Tony in their new roles, our market-leading endoscopic spine technologies, and our anticipated launch of two more new surgical access systems later in 2023, we are well positioned for another very successful year.”